A clinical trial to study the drug of senkaluneer chooranam on vatha piththam

Phase 2

Recruiting

• Conditions: VATHA PITHTHAM PRIMARY SYSTEMIC HYPERTENSION DISEASE

• Registration Number: CTRI/2018/04/013523
• Lead Sponsor: Prof Dr S Neelavathi

Brief Summary

The Study is Prospective Open Labeled Randomized Phase II Clinical Trial to Evaluate the Therapeutic Efficacy of Trail Drug SENKALUNEER CHOORANAM 800mg 1000mg tds for 30 days on the 40 Patients with VATHA PITHTHAM that will be conducted in Government Siddha Medical College and Hospital Palayamkottai The Primary Out come Therapeutic efficacy of SENKALUNEER CHOORANAM The Sencondary will be the Evaluation of Siddha Diagnostic Parameters

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-27
• Last Update Posted: 2018-12-04

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Patient with Symtoms Headache Giddiness Palpitation Dizziness Dyspnoea Shortness of Breath Fatigue Blood Pressure Systolic 140.
• 159 mmHg Diastolic 90.

Exclusion Criteria

Secondary Hypertension High Risk Pregnancy Hypertension Associated Cerebro Vascular Accident Ischemic Heart Disease Chronic Alcoholism Chronic Liver Disease Chronic Renal Disease Endocrine Disorder.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To Evaluate the Therapeutic Efficacy of KALUNEER CHOORANAM in the Treatment of VATHA PITHTHAM	30 Days

Secondary Outcome Measures

Name	Time	Method
To Evaluate the Siddha Cofactor Towords the Efficacy of the Trial Drug SENKALUNEER CHOORANAM and to Evaluate the Pharmacological Action	30 Days

Trial Locations

Locations (1)

Government Siddha Medical College and Hospital; 🇮🇳 Tirunelveli, TAMIL NADU, India

Government Siddha Medical College and Hospital

🇮🇳Tirunelveli, TAMIL NADU, India

DR VETTIVEL JEGATHEESWARAN

Principal investigator

9894468423

jegatheeswaran79@gmail.com